{"id":242721,"date":"2026-08-14T14:06:45","date_gmt":"2026-08-14T19:06:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/08\/ketamine-and-psychotherapy-show-promise-as-a-combined-approach-to-chronic-neuropathic-pain"},"modified":"2026-08-14T14:06:45","modified_gmt":"2026-08-14T19:06:45","slug":"ketamine-and-psychotherapy-show-promise-as-a-combined-approach-to-chronic-neuropathic-pain","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/08\/ketamine-and-psychotherapy-show-promise-as-a-combined-approach-to-chronic-neuropathic-pain","title":{"rendered":"Ketamine and psychotherapy show promise as a combined approach to chronic neuropathic pain"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/ketamine-and-psychotherapy-show-promise-as-a-combined-approach-to-chronic-neuropathic-pain2.jpg\"><\/a><\/p>\n<p>Combining ketamine and psychotherapy is a safe and feasible approach with promising benefits for people experiencing chronic neuropathic pain, according to a new study by researchers at St. Michael\u2019s Hospital, the University of Toronto and York University.<\/p>\n<p>\u201cThis is a novel treatment paradigm for a patient population that is suffering greatly,\u201d says Akash Goel, the study\u2019s lead author, a clinician-investigator at St. Michael\u2019s Hospital, a site of Unity Health Toronto, and an assistant professor of anesthesiology and pain medicine at the University of Toronto\u2019s Temerty Faculty of Medicine.<\/p>\n<p>The trial was conducted at St. Michael\u2019s Hospital between 2023 and 2025 and enrolled 30 participants with chronic neuropathic pain who were randomly assigned to receive one of three treatments: ketamine infusions, weekly psychotherapy sessions or both. Each treatment program lasted 16 weeks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Combining ketamine and psychotherapy is a safe and feasible approach with promising benefits for people experiencing chronic neuropathic pain, according to a new study by researchers at St. Michael\u2019s Hospital, the University of Toronto and York University. \u201cThis is a novel treatment paradigm for a patient population that is suffering greatly,\u201d says Akash Goel, the [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-242721","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=242721"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242721\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=242721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=242721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=242721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}